Development of novel antibacterial agents against methicillin-resistant Staphylococcus aureus.
about
Delivery of host cell-directed therapeutics for intracellular pathogen clearanceIn vitro and in vivo activity of a novel sorafenib derivative SC5005 against MRSA.Repurposing celecoxib as a topical antimicrobial agent.Advances in MRSA drug discovery: where are we and where do we need to be?AR-13, a Celecoxib Derivative, Directly Kills Francisella In Vitro and Aids Clearance and Mouse Survival In Vivo.
P2860
Development of novel antibacterial agents against methicillin-resistant Staphylococcus aureus.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Development of novel antibacte ...... sistant Staphylococcus aureus.
@ast
Development of novel antibacte ...... sistant Staphylococcus aureus.
@en
Development of novel antibacte ...... sistant Staphylococcus aureus.
@nl
type
label
Development of novel antibacte ...... sistant Staphylococcus aureus.
@ast
Development of novel antibacte ...... sistant Staphylococcus aureus.
@en
Development of novel antibacte ...... sistant Staphylococcus aureus.
@nl
prefLabel
Development of novel antibacte ...... sistant Staphylococcus aureus.
@ast
Development of novel antibacte ...... sistant Staphylococcus aureus.
@en
Development of novel antibacte ...... sistant Staphylococcus aureus.
@nl
P2093
P2860
P1476
Development of novel antibacte ...... sistant Staphylococcus aureus.
@en
P2093
Ching-Shih Chen
Dasheng Wang
Hao-Chieh Chiu
Lee-Jene Teng
Naval Kapuriya
Samuel K Kulp
Su-Lin Lee
Sung-Liang Yu
Yi-Ru Chen
P2860
P304
P356
10.1016/J.BMC.2012.06.018
P407
P577
2012-06-15T00:00:00Z